-
Signature
-
/s/Lisa Stockard as Attorney-in-Fact
-
Issuer symbol
-
EFX
-
Transactions as of
-
28 Apr 2025
-
Net transactions value
-
-$1,797,841
-
Form type
-
4
-
Filing time
-
30 Apr 2025, 16:21:01 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EFX |
Common Stock |
Options Exercise |
$3,888,637 |
+22,160 |
+16% |
$175.48 |
164,555 |
28 Apr 2025 |
Direct |
F1, F2 |
| transaction |
EFX |
Common Stock |
Sale |
$5,686,478 |
-22,160 |
-13% |
$256.61 |
142,395 |
28 Apr 2025 |
Direct |
F1, F2 |
| holding |
EFX |
Common Stock |
|
|
|
|
|
43,382 |
28 Apr 2025 |
2-yr 2023 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
10,500 |
28 Apr 2025 |
2-yr 2025 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
9,525 |
28 Apr 2025 |
2-yr Feb 2024 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
24,125 |
28 Apr 2025 |
2-yr Jul 2024 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
24,225 |
28 Apr 2025 |
3-yr Jul 2024 GRAT |
|
| holding |
EFX |
Common Stock |
|
|
|
|
|
12,333 |
28 Apr 2025 |
4-yr 2021 GRAT |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EFX |
Stock Option/Right to Buy |
Options Exercise |
$0 |
-22,160 |
-100% |
$0.000000 |
0 |
28 Apr 2025 |
Common Stock |
22,160 |
$175.48 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: